These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cancer chronotherapy: is there a right time in the day to treat? Hrushesky WJ J Infus Chemother; 1995; 5(1):38-43. PubMed ID: 7634176 [TBL] [Abstract][Full Text] [Related]
4. Biochemical basis for circadian-dependent metabolism of fluoropyrimidines. Daher GC; Harris BE; Willard EM; Diasio RB Ann N Y Acad Sci; 1991; 618():350-61. PubMed ID: 1826077 [No Abstract] [Full Text] [Related]
5. Clinical cancer chronotherapy trials: a review. Bjarnason GA J Infus Chemother; 1995; 5(1):31-7. PubMed ID: 7634175 [TBL] [Abstract][Full Text] [Related]
6. More evidence for circadian rhythm effects in cancer chemotherapy: the fluoropyrimidine story. Hrushesky WJ Cancer Cells; 1990 Mar; 2(3):65-8. PubMed ID: 2143918 [No Abstract] [Full Text] [Related]
7. Cancer chronotherapy: a drug delivery challenge. Hrushesky WJ Prog Clin Biol Res; 1990; 341A():1-10. PubMed ID: 2145583 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic aspects of arterial fluoropyrimidine delivery. Collins JM Ann N Y Acad Sci; 1991; 618():345-9. PubMed ID: 1826076 [No Abstract] [Full Text] [Related]
9. A phase I trial of immediate postoperative intraperitoneal floxuridine and leucovorin plus systemic 5-fluorouracil and levamisole after resection of high risk colon cancer. Kelsen DP; Saltz L; Cohen AM; Yao TJ; Enker W; Tong W; Tao Y; Bertino JR Cancer; 1994 Oct; 74(8):2224-33. PubMed ID: 7922973 [TBL] [Abstract][Full Text] [Related]
11. [Potentialities of fluorine-19 and phosphorus-31 NMR for studying the metabolism and pharmacokinetics of fluorinated or phosphoric antineoplastic agents]. Martino R; Malet-Martino MC; Armand JP; De Forni M Bull Cancer; 1989; 76(8):859-61. PubMed ID: 2533514 [No Abstract] [Full Text] [Related]
12. Identifying mechanisms of chronotolerance and chronoefficacy for the anticancer drugs 5-fluorouracil and oxaliplatin by computational modeling. Altinok A; Lévi F; Goldbeter A Eur J Pharm Sci; 2009 Jan; 36(1):20-38. PubMed ID: 19041394 [TBL] [Abstract][Full Text] [Related]
13. Is hepatic infusion of chemotherapy effective treatment for liver metastases? Yes! Kemeny NE Important Adv Oncol; 1992; ():207-27. PubMed ID: 1533847 [No Abstract] [Full Text] [Related]
14. [Doxifluridine toxicity, a fluorouracil analog with low myelosuppressive effect]. Winkelmann JJ; Alberto P; Mermillod B Bull Cancer; 1990; 77(3):225-34. PubMed ID: 2140280 [TBL] [Abstract][Full Text] [Related]
15. [The study of 5-FU levels and pyrimidine nucleoside phosphorylase (PyNPase) activity in human breast cancer tissue after administration of 5'-deoxy-5-fluorouridine (5'-DFUR)]. Yayoi E; Takatsuka Y; Miyauchi K; Hirai T; Aikawa T; Maeura Y; Kaji M; Kitada M; Kotsuma Y; Satomi T Gan To Kagaku Ryoho; 1990 Jul; 17(7):1371-4. PubMed ID: 2142401 [No Abstract] [Full Text] [Related]
16. Development of an LC-MS/MS assay for the quantitative determination of the intracellular 5-fluorouracil nucleotides responsible for the anticancer effect of 5-fluorouracil. Derissen EJ; Hillebrand MJ; Rosing H; Schellens JH; Beijnen JH J Pharm Biomed Anal; 2015 Jun; 110():58-66. PubMed ID: 25804433 [TBL] [Abstract][Full Text] [Related]
18. Dose-dependent metabolism, therapeutic effect, and toxicity of anticancer drugs in man. Powis G Drug Metab Rev; 1983; 14(6):1145-63. PubMed ID: 6373208 [TBL] [Abstract][Full Text] [Related]
19. [A study of preoperative administration of 5'-DFUR in patients with colo-rectal cancer]. Haruta A; Umeno T; Tanaka S; Toriya H; Jyozaki H; Ikeda S Gan To Kagaku Ryoho; 1994 Oct; 21(14):2427-30. PubMed ID: 7944487 [TBL] [Abstract][Full Text] [Related]
20. Modulation of the pharmacokinetics of 5'-deoxy-5-fluorouridine and 5-fluorouracil in rats by oral co-administration of acyclothymidine. Hamada A; Fukushima S; Saneyoshi M; Shimizu S; Kawaguchi T; Nakano M Biol Pharm Bull; 1996 May; 19(5):729-32. PubMed ID: 8741584 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]